Gill Eapen is a Managing Director in the Management Consulting group. He has extensive experience in strategy, finance, engineering, risk and general management.

Gill has advised clients over a broad range of industries. He has more than 30 years of experience in artificial intelligence and was instrumental in creating and implementing one of the first and largest predictive models to forecast and manage R&D resources at one of the leading global pharmaceutical companies. He also developed an automated trading platform to manage a long/short, market-neutral equity fund, showing consistent alpha over an extended period of time.

Gill is the author of two textbooks. The first book, Decision Options: The Art and Science of Making Decisions, provides the theory and practice of real options in economic valuation and investment decision-making in private assets. The second book, Flexibility: Flexible Companies for the Uncertain World, is a comprehensive discussion of the structure, systems, and strategies needed for companies to survive and succeed in an increasingly uncertain world. 

Prior to joining Stout, he was Founder and Chairman of the Board of Decision Options, LLC.

Select Publications

  • CRC Press December 2009

    Flexibility: Flexible Companies for the Uncertain World
  • CRC Press June 2009

    Decision Options: The Art and Science of Making Decisions
  • Journal of Applied Corporate Finance March 2005

    Value-Based Management in Biosciences Research and Development
  • Journal of Applied Corporate Finance December 2002

    The Accidental Real Options Practitioner
  • Journal of Applied Corporate Finance April 2002

    University of Maryland Roundtable on Real Options and Corporate Practice

Select Presentations and Speeches

  • The Michigan Association of Certified Public Accountants May 2017

    Decision Options®: Stout’s Predictive Analytics and Economic Modeling Platform
  • FEI’s Current Financial Reporting Issues Conference October 2016

    Using Analytics to Improve the Capital Budgeting Process
  • Cambridge Healthtech Institute’s and the BioPhama Strategy Series’ 11th Annual Portfolio Management: Aligning Portfolio and Productivity with Corporate Strategy to Drive Innovation Conference September 2016

    Predictive Analytics and Economic Valuation in Portfolio Management of Life Sciences Assets
  • Chief Innovation Officer Summit June 2016

    Accelerating Innovation by Harvesting Uncertainty
  • 8th Life Science Financial Forum March 2016

    Using Predictive Decision Analytics in Resource Allocation and Portfolio Management
  • Electric Utilities Environment Conference February 2013

    Value of Design Flexibility
  • Loyola Institute of Business Administration July 2009

    Economic Valuation and Decision Making
  • IQPC Conference in Philadelphia February 2009

    Value Based Decision Making in Pharmaceuticals
  • INFORMS Annual Meeting November 2007

    Practice of Risk Management